Growth Metrics

Cytek Biosciences (CTKB) Other Working Capital Changes (2020 - 2025)

Cytek Biosciences' Other Working Capital Changes history spans 6 years, with the latest figure at $4.3 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 15.91% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $3.6 million, up 28.2%, while the annual FY2025 figure was $3.6 million, 28.2% up from the prior year.
  • Other Working Capital Changes reached $4.3 million in Q4 2025 per CTKB's latest filing, up from -$1.1 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $20.8 million in Q4 2022 to a low of -$7.9 million in Q3 2023.
  • Average Other Working Capital Changes over 5 years is $1.9 million, with a median of $1.2 million recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: tumbled 656.63% in 2022, then skyrocketed 2502.02% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at $1.2 million in 2021, then skyrocketed by 1561.6% to $20.8 million in 2022, then crashed by 58.24% to $8.7 million in 2023, then crashed by 41.1% to $5.1 million in 2024, then decreased by 15.91% to $4.3 million in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Other Working Capital Changes are $4.3 million (Q4 2025), -$1.1 million (Q3 2025), and $1.5 million (Q2 2025).